sm5 (1)

download sm5 (1)

of 13

Transcript of sm5 (1)

  • 8/12/2019 sm5 (1)

    1/13

    Host response in aggressiveperiodontitis

    CY E L E E KU L K A R N I & DE N I S F. KI N A N E

    As a preliminary to discussing the host response in

    aggressive periodontitis it is worthwhile considering

    briey the classication and presentation of this dis-

    ease entity. There are numerous periodontal diseases

    that affect children and adolescents. Previous classi-

    cation systems dened the common forms of chronic

    periodontal diseases by age of onset and named this

    group early-onset periodontitis. Classication sys-

    tems for periodontal diseases changed in recognition

    of the signicant overlap between these categories.

    Newer classication systems have reclassied

    periodontitis into three major forms: chronic perio-

    dontitis; aggressive periodontitis; and necrotizing

    periodontitis (38). We now refer to early-onset peri-

    odontitis as aggressive periodontitis.

    The prevalence of chronic periodontal disease

    increases with age, with periodontitis being quite rare

    in the

    rst three decades of life. Aggressive periodon-titis manifesting in children and adolescents is again

    quite uncommon, affecting typically

  • 8/12/2019 sm5 (1)

    2/13

    deciencies in host defenses.

    genetic predisposition.

    This volume of Periodontology 2000 includes articles

    dealing in depth with microbial aspects and genetic

    predisposition, and this article will focus on host

    defenses and deciencies whilst discussing the

    microbial etiology as it initiates disease and the

    genetic background to the host-defense deciencies

    in general.The term periodontal diseases encompasses the

    full spectrum of inammatory periodontal diseases,

    from gingivitis to all forms of periodontitis, including

    chronic, aggressive and necrotizing forms. The Euro-

    pean Workshop in Periodontology (32) declared gin-

    givitis and periodontitis as a continuum of the same

    chronic inammatory condition that affects the

    supporting structures of the teeth (32). It was previ-

    ously believed that gingivitis was an inevitable conse-

    quence of microbial plaque accumulation on the

    teeth; however, it is now recognized that inherent

    patient susceptibility plays a large role in the expres-

    sion of gingivitis and its progression to periodontitis.

    Gingivitis occurs in a signicant percentage of the

    population, whereas advanced chronic periodontitis,

    leading to multiple tooth loss, develops in only a frac-

    tion of the population (1015%) (30). The progression

    of gingivitis to periodontitis is thought to be inu-

    enced by the individuals immune and inamma-

    tory responses. Chronic periodontitis and aggressive

    periodontitis are among the more signicant of the

    periodontal diseases as they result in tooth loss but,

    given the progression from gingivitis to periodontitis,prevention of gingivitis may be more important than

    previously thought.

    Concept of susceptibility

    Differences among individuals in the response to

    bacterial plaque may be a result of variation in host

    susceptibility, with some individuals being very

    susceptible and developing aggressive forms of peri-

    odontitis at a relatively young age, whilst others might

    be resistant and will never develop periodontitis (36).The majority of the population falls within this range

    and will develop a degree of gingival inammation

    and possibly some periodontal disease over time

    when exposed to bacterial plaque. The rate at which

    this develops can vary between individuals, with

    some experiencing a slow progressing disease over

    the course of a lifetime and others developing more

    rapid and severe periodontal tissue destruction

    resulting in tooth loss. It has been suggested that an

    excessive host immune response to the periodontal

    microora may also be partly responsible for varia-

    tion in the disease response but so far this has not

    been well supported by scientic research. An exces-

    sive monocyte/macrophage response can be found in

    patients with periodontitis compared with subjects

    with no periodontitis (22, 61). Engebretson et al. (18)

    have shown that periodontal indices are strongly cor-

    related with the levels of inammatory cytokines ingingival crevicular uid. However, thus far these

    inammatory markers have not shown diagnostic

    utility, and a better understanding of the host-

    response processes is needed to furnish better diag-

    nostic aids for clinical application.

    Numerous etiological factors are responsible for

    the ultimate expression of periodontal disease.

    Clearly, bacterial plaque accounts for only a portion

    of the risk of an individual and therefore other

    factors must also be considered, including host

    factors, environmental factors and genetic factors.

    Each component modies the individuals manifesta-

    tion of the severity and progression of periodontal

    diseases.

    Susceptibility to gingivalinammation

    Susceptibility to gingivitis is supported by literature

    showing that subjects have a highly variable rate of

    development of gingivitis. Weidmann et al. (75)

    reported a group of 62 subjects in whom a wide rangeof host responses occurred after withdrawal of oral

    hygiene measures for 21 days; a susceptible group

    who exhibited signicant gingival inammation

    within 14 days; and an intermediate group (the

    majority) who developed gingival inammation by

    day 21. This separation of resistant and susceptible

    individuals has been observed in several studies (1,

    41, 42) with an across-studies estimate indicating

    that this resistant group makes up 13% of subjects.

    Trombelli et al. (73) and Engebreton et al. (18) have

    shown that there are interindividual differences in

    the response to dental plaque in gingivitis studies. Allsubjects expressed some gingivitis, but some devel-

    oped much more severe and rapid inammation.

    These interindividual differences may be explained

    by genetics or environmental factors but preliminary

    genetic evidence supports the possibility that there

    are interindividual differences in the ability to

    develop gingival inammation and showed that spe-

    cic genetic characteristics (for example interleukin-

    1 polymorphisms) may contribute to exacerbated

    Kulkarni & Kinane

    80

  • 8/12/2019 sm5 (1)

    3/13

    gingival inammation in response to plaque accu-

    mulation. The relationship between an individuals

    susceptibility to gingivitis and their susceptibility to

    the development of periodontitis is currently

    unclear. Those who develop excessive gingivitis may

    also be expected to be prone to developing aggres-

    sive periodontitis. However, clinically, subjects with

    aggressive periodontitis appear to have dispropor-

    tionately low levels of bacterial plaque and inam-mation relative to the degree of periodontal

    destruction. In the case of smokers, there are simi-

    larly low levels of gingival inammation, presumably

    owing to the restriction of blood ow, and yet a high

    level of periodontal disease. In smokers, environ-

    mental factors play a role in masking the presence of

    gingivitis and in the aggravation of periodontal dis-

    ease. This begs the question: is there a link between

    gingivitis susceptibility and periodontitis in which

    environmental or other risk factors play a role in

    modifying the connection or are the two completely

    independent entities with distinct etiologies?

    Numerous studies have shown genetic modulation

    in the susceptibility of an individual to develop

    gingivitis but how this relates to periodontitis is yet

    to be determined. For the clinician, the ability to

    determine a patients susceptibility, either through

    genetic markers or otherwise, may play a major role

    in determining a course of treatment. For example,

    in a susceptible child or adolescent undergoing

    orthodontic treatment it can be expected that gingi-

    vitis will occur much more rapidly or severely than

    in other patients and thus a more rigorous recallschedule may be warranted for this patient. Or per-

    haps in a patient requiring a crown, the practitioner

    may opt to alter the nish line to be supragingival to

    prevent an unwanted localized inammatory

    response in a patient who is susceptible to gingivitis

    compared with one who is resistant.

    In contrast to gingivitis, susceptibility to advanced

    periodontitis with multiple tooth-loss is seen in only

    a subset of the population (1015%) (6). It is vari-

    able in that it does not affect all teeth to the same

    extent, but has both a subject and a site predilec-

    tion. Aggressive periodontitis is most commonwithin the rst three decades of life and, speci-

    cally, localized aggressive periodontitis is typically

    localized to the permanent rst molars and incisors

    and often occurs circumpubertally. Retrospective

    data in some studies of patients with localized

    aggressive periodontitis have suggested that bone

    loss in the primary dentition may be an early sign

    of disease (63). The review on genetics in this vol-

    ume of Periodontology 2000 may give a more com-

    plete understanding of genetic susceptibility as it

    pertains to clinical disease entities but at the same

    time there is considerable complexity in that sus-

    ceptibility to gingivitis may be related to susceptibil-

    ity to aggressive or chronic periodontitis and our

    clear ability to diagnose and categorize disease ef-

    ciently will impact on our ability to discover and

    prove underlying genetic causes.

    Risk factors

    The presence of a risk factor implies a direct

    increase in the probability of a disease occurring.

    Periodontal disease is considered to have multiple

    risk factors (4). The term risk factor refers to an

    aspect of personal behaviour or lifestyle, an envi-

    ronmental exposure, or an inborn or inherited char-

    acteristic, which on the basis of epidemiological

    evidence is known to be associated with a health

    related condition. Risk factors are part of the causal

    chain for a particular disease or can lead to expo-

    sure of the host to a disease. In periodontal disease

    there are numerous pathogens that have been iden-

    tied as potential key risk factors; however, it has

    become clear that although necessary, the presence

    of the pathogens is not sufcient for disease to

    occur. The presence of microorganisms is a crucial

    factor in inammatory periodontal disease, but the

    progression of the disease is related to host-based

    risk factors. Aggressive periodontal disease is a mul-

    tifactorial process that results from a combination ofgenetic, environmental, host and microbial factors

    (37).

    Specic inammatory and immuneprocesses in periodontal disease

    Variation in susceptibility to periodontitis is well rec-

    ognized. However, the pathological basis of this

    range of disease expression is poorly understood. In

    particular, despite the availability of signicant infor-

    mation regarding the inammatory and immuneprocesses involved in periodontitis, the differences

    between the pathology of chronic periodontitis vs.

    aggressive periodontitis have not been clearly identi-

    ed. Thus, the task of deriving clinically important

    messages is unpromising from the outset. In contrast

    to gingivitis, the host response in periodontal disease

    produces plasma-cell-dominated lesions. Genetic

    and environmental factors modify and affect the

    host response; however, it has yet to be determined

    Aggressive periodontitis host factors

    81

  • 8/12/2019 sm5 (1)

    4/13

    how, and to what degree, these factors inuence

    immune and inammatory processes. Aspects of the

    inammatory and immune processes both

    humoral and cellularwhich develop in response to

    the microbial insult from dental plaque could be

    important areas for therapeutics and diagnostics in

    the future but are currently too poorly understood

    to be of use. Whilst some inammatory and immune

    responses are expected in the presence of a micro-bial biolm, the excessive plasma-cell inltrate seen

    in periodontitis may be illustrative of an individuals

    inability to defend against periodontal pathogens

    and thus may indicate a predisposition to periodon-

    titis. However, short of excising tissue we have little

    way of utilizing this information diagnostically and

    prognostically.

    Bacterial risk factors

    Examples of microbes implicated as risk factors in

    periodontitis are numerous. Carlos et al. (12) found

    that the presence ofPrevotella intermedia, along with

    gingival bleeding and calculus, was correlated with

    attachment loss in a group of Navajo adolescents,

    1419 years of age. Grossi et al. (26) found that Por-

    phyromonas gingivalisand Tannerella forsythiawere

    associated with increased risk for attachment loss as a

    measure of periodontal disease, after adjustment for

    age, plaque, smoking and diabetes. The problem with

    these types of microbial disease-association studies is

    that the microbial plaque microbiome which is impli-cated in initiating disease has a vast and varied num-

    ber of microorganisms (21), possibly also including

    viruses and even, in some cases, protozoa.

    In the past, the predominant microorganism found

    in localized aggressive periodontitis was reported as

    A. actinomycetemycomitans, but the supporting litera-

    ture does not survive close scrutiny and in the paper

    by Faveri et al. (20) the level ofA. actinomycetemyco-

    mitans was below the detection limit of their well-

    conducted study. Multiple studies showed markedly

    elevated levels of serum antibody to A. actinomycete-

    mycomitansin patients with localized aggressive peri-odontitis (7, 16, 43). In patients with localized

    aggressive periodontitis who were treated success-

    fully, there was signicant reduction or elimination

    of A. actinomycetemycomitans. In those who failed

    treatment, persistent levels ofA. actinomycetemycom-

    itanswere found in the affected sites (47, 58). The rea-

    son for this nding may be explained by the presence

    of antibodies that are cross-reactive across gram-neg-

    ative species, and therefore although the titers of anti-

    body to A. actinomycetemycomitans were reduced,

    this was a reection more of a broad reduction in

    antibody titers against gram-negative anaerobic rods

    than specic support for the importance of one par-

    ticular bacterium over the many others in the oral

    microbial biolm relevant to periodontal disease.

    An important aspect of any pathogens ability to

    affect a host is its virulence factor. A. actinomycete-

    mycomitans has been shown to produce a leuko-toxin an exotoxin with the primary toxic effect of

    leukocyte destruction, specically of polymorpho-

    nuclear neurophils of the host (65, 79). This quality

    has been regarded as one of the key reasons for

    this species predominance in localized aggressive

    periodontitis. Despite these compelling studies, the

    idea that A. actinomycetemycomitans is the causa-

    tive agent of localized aggressive periodontitis has

    not gone undisputed. Numerous studies have

    shown that although highly prevalent in most cases

    of localized aggressive periodontitis, A. actinomycet-

    emycomitans is not present in all cases of localized

    aggressive periodontitis. Several cross-sectional

    studies (13, 17, 25, 49, 75) showed that there is a

    generally high prevalence of A. actinomycetemycom-

    itans in many populations, particularly in develop-

    ing countries. Studies have also indicated that

    A. actinomycetemycomitans has been detected in

    subgingival plaque in the absence of localized

    aggressive periodontitis. Conversely, there have also

    been reports of patients with localized aggressive

    periodontitis without detectable A. actinomycetemy-

    comitans, and in the comprehensive molecularstudy of the aggressive periodontitis microbiome

    performed by Faveri et al. (20) they could not

    detect A. actinomycetemycomitans and dismissed it

    as a relevant microorganism in their population.

    Clearly, A. actinomycetemycomitans has, in the past,

    been considered to play an important role in local-

    ized aggressive periodontitis but this is question-

    able in non-black populations and calls into

    question the clinical recommendation to use tetra-

    cycline in the treatment of aggressive periodontitis

    and the clinical relevance of the extensive studies

    on leukotoxin and cytolethal distending toxin.The inammatory and immune responses in the

    gingival pocket of periodontal patients are presumed

    to be initiated and perpetuated by gram-negative

    anaerobic rods and spirochetes. Knowledge of the

    causal bacteria in periodontitis, other than the appre-

    ciation that a biolm containing predominantly

    gram-negative anaerobic rods and anaerobic spiro-

    chetes pertains, does not as yet help in the manage-

    ment of periodontitis other than suggesting that if an

    Kulkarni & Kinane

    82

  • 8/12/2019 sm5 (1)

    5/13

  • 8/12/2019 sm5 (1)

    6/13

    Genco (64), Tanner et al. (71) and recently Dewhirst

    and colleagues (15) identied several gram-negative

    bacterial species as putative pathogens in oral tissue

    destruction.

    Innate immunity to oral pathogens

    Theeld of innate immunity has mushroomed during

    the past decade, mainly because of the identication

    of pathogen-recognition receptors and mechanisticcellular signaling pathways related to it. Several of

    these pathogen-recognition receptors have been

    identied and characterized, including toll-like

    receptors, Nod-like receptors, RIG-like receptors and

    dectins as pathogen sensors (50). More recently,

    co-operation between different receptors (including

    chemokine receptors, integrins, G-protein coupled

    receptors and the complement system) and their cel-

    lular signaling pathways in recognizing pathogens

    and mounting an innate immune response, particu-

    larly to oral pathogens have been elucidated (19). In

    the context of polymicrobial infection, the immune

    response triggered may be a result of the simulta-

    neous activation of several cellular signaling path-

    ways and it is unlikely that a signaling pathway is

    activated in isolation. All of these pathways and

    receptors may have a critical role in the etiology of

    aggressive periodontitis and, similarly, variations in

    these molecules may be induced by genetic variants

    that might be the critical predisposing genetic factors

    in aggressive periodontitis hereditability. Thus, they

    are worthy of study.

    Toll-like receptors are among the most studiedpattern-recognition receptors as a result of their role

    in detecting varied pathogen-associated molecular

    patterns. So far, 10 human toll-like receptors have

    been identied with the ability to recognize specic

    microbial structures (31). Specically, toll-like recep-

    tor 4 recognizes the lipopolysaccharide of gram-

    negative bacteria, and toll-like receptor 2 forms

    heterodimers with toll-like receptor 1 or toll-like

    receptor 6 and recognizes peptidoglycan, lipopeptide

    and lipoproteins. Double-stranded RNA is recognized

    by toll-like receptor 3, whereas toll-like receptor 5 can

    detect bacterial agellin. Toll-like receptor 7, toll-likereceptor 8 and toll-like receptor 9 recognize bacterial

    and viral molecules. Once these receptors, with the

    help of co-receptors or adaptor molecules, recognize

    pathogen-related biomolecules, several intracellular

    signaling events occur, leading to the production of

    inammatory cytokines, antimicrobial peptides, co-

    stimulatory molecules, type I interferons and chemo-

    kines to mount the innate immune response (11).

    Any of these defensive response molecules could be

    defective and be part of the specic susceptibility

    associated with aggressive periodontitis [see Fig. 1

    (10)].

    The innate immune response is also critical in acti-

    vating antigen-presenting cells and thus in stimulat-

    ing the adaptive immune responses. Polymicrobial

    infection seems to be much more complicated, in

    terms of cellular activation, than originally thought

    and again this complicates our understanding of theetiology and susceptibility in aggressive periodontitis.

    Considering the diversity of microorganisms in bio-

    lm colonization, activation of multiple signaling

    pathways simultaneously seems to be relevant in

    polymicrobial-related persistent inammation, as in

    aggressive periodontitis.

    Thus, the role of innate immune cells is generally to

    detect microbes and maintain hostmicrobe immune

    homeostasis and to induce antimicrobial defense

    mechanisms. Innate immune cells, such as epithelial

    cells, broblasts, dendritic cells, macrophages and

    neutrophils, act as the rst line of defense against

    invading pathogens and, through the actions of anti-

    gen-presenting cells (dendritic cells and macro-

    phages), mount an adaptive immune response. Of

    these cells, the most discussed in the context of the

    etiopathology of aggressive periodontitis is the poly-

    morphonuclear neutrophil. A large body of literature

    in the 1970s and 1980s supported the concept of pre-

    disposition to juvenile periodontitis (as it was then

    called) as a result of a polymorphonuclear neutrophil

    chemotactic defect (24). Kinane et al. (33, 34) per-

    formed an extensive study of polymorphonuclearneutrophil chemotaxis from a series of these patients

    with aggressive periodontitis and found not only no

    defect, but rather an overactivation of these cells in

    the peripheral blood of patients with aggressive

    periodontitis. Thus, although polymorphonuclear

    neutrophils are critical in the defense of the peri-

    odontium, as evidenced by the rapid destruction in

    conditions such as leukocyte adhesion deciency, a

    neutrophil chemotactic defect does not appear to be

    the key mechanism. There are, however, systemic dis-

    eases, in addition to leukocyte adhesion deciency,

    which have defective polymorphonuclear neutrophilsas a result of the absence of a crucial trafcking mole-

    cule. Such diseases include PapillonLefevre syn-

    drome, in which a neutrophil antimicrobial molecule,

    cathepsin C, is missing and this renders the patient

    also susceptible to an early-onset form of periodontitis,

    which is similar to, but different from, aggressive peri-

    odontitis (37). Clearly, researchers attempting to uncover

    the genetic etiology of aggressive periodontitis have

    researched, and continue to research, these promising

    Kulkarni & Kinane

    84

  • 8/12/2019 sm5 (1)

    7/13

    molecules and pathways in the search for the underlying

    genetic predisposition to aggressive periodontitis.

    Immune responses

    Even in a state of general health, periodontal tissues

    will almost always exhibit a degree of leukocyte inl-

    trate because of the constant pressures of microbial

    biolm and deposits adjacent to tissues. In a state ofdisease the tissues of the periodontium show

    increased tissue turnover and cellular activity associ-

    ated with inltrating inammatory cells (54). It has

    been suggested in the literature that signicant num-

    bers of B-cells and T-cells accumulate in these tissues;

    however, the functions of these cells in the periodon-

    tal-disease process in not well understood.

    Literature describing the host response, at a cellular

    level, in periodontal disease is often fraught with con-

    tradictory remarks including periodontitis is a B-cell

    lesion and the immunoregulatory role of T-cells in

    periodontitis (46, 51, 52, 59). These observations are

    often a result of immunohistochemical methods used

    to determine lymphocyte subsets. While specic

    observations are noted using these methods, the

    inter-relationship between various types of cells can-

    not be directly elucidated. For example, while T-cells

    are implicated in immunoglobulin synthesis in vitro

    (29, 51, 53), the results of these studies do not easilyextrapolate to in-vivo situations where complex

    interactions between a variety of inltrated inamma-

    tory cells occur. In these studies it is often difcult to

    assess the role of the different cell types based on lim-

    ited observations and immunochemical analysis, and

    so the true function and inter-relationship between

    the various types of cells often remains unknown.

    Data suggest that both B-cells and T-cells are long

    lived in gingival tissues and in periodontal granula-

    Fig. 1. A simplied signaling cascade in the oral biolm,

    activated by toll-like receptors and by the toll-like receptor

    cross-talk pathway. Cellular signaling to oral biolms may

    activate several unidentied pathways, leading to the release

    of cytokines, chemokines, interferon and antimicrobial pep-

    tides. These released molecules amplify the inammation

    and help to kill the bacteria of the biolm, and also aid in

    the recruitment of phagocytes to perform this task and ulti-

    mately aid in the restoration of homeostasis to the recovered

    tissues. Adapted from Benakanakere & Kinane (10). cAMP,

    cyclic AMP; CXCR, CXC chemokine receptor; EDGR, epider-mal growth factor receptor; IL, interleukin; iNOS, inducible

    nitric oxide synthase; IPAF, ICE protease-activating factor;

    IRF, interferon regulatory factor; mTOR, mammalian target

    of rapamycin; MyD88, myeloid differentiation primary

    response gene (88); NALP, NALP inammasome; NF-jB,

    nuclear factor-kappaB; NOD, nucleotide oligomerization

    domain; PAR, protease-activated receptor; PI3K, phospho-

    inositide 3-kinase; PKA, protein kinase A; RIG-1/MDA5, reti-

    noid-inducible gene 1/melanoma differentiation-associated

    protein 5; S1P, sphingosine-1-phosphate; Sphk1, sphingo-

    sine kinase 1; TNFR, tumor necrosis factor receptor; TLR,

    toll-like receptor; TRIF, TIR-domain-containing adapter-inducing interferon beta.

    Aggressive periodontitis host factors

    85

  • 8/12/2019 sm5 (1)

    8/13

    tion tissues. These cells probably have the ability to

    migrate between blood and lymph pathways in order

    to participate in the immune response (39). This is

    supported by the ndings that: (i) CD5-positive B-

    cells are present in the gingiva at higher proportions

    than in the blood(68); (ii) activated B-cells are present

    in the periodontium(76); and (iii) CD5-positive B-cells

    do not proliferate (2).

    T-cells behave as a double-edged sword; whilstnecessary for host protection from bacterial invasion,

    the release of excessive amounts of cytokines from T-

    cells will result in damage to the host because of their

    tissue-degradative properties. The function of the T-

    cell in a lesion can be determined by the cytokines

    that they release. T-helper (CD4+) cells can be catego-

    rized into three subgroups based on their cytokine

    prole: T-helper 1 cells (which secrete interleukin-2,

    interleukin-12, tumor necrosis factor alpha and inter-

    feron gamma); T-helper 2 cells (which secrete inter-

    leukin-4, interleukin-5, interleukin-6, interleukin-10

    and interleukin-13); and T-helper 17 cells (which

    secrete interleukin 17 and are transforming growth

    factor beta-related) (27). Numerous studies have

    focused on the roles of these T-cells, particularly T-

    helper 1 cells and T-helper 2 cells, in the periodon-

    tium. Recent studies suggest that whilst both T-helper

    1 cells and T-helper 2 cells exist in the periodontium,

    T-helper 2 cells are more abundant than T-helper 1

    cells in periodontal-disease sites (9, 23, 40, 48, 62, 78).

    Recent studies conrm that cytokines from both T-

    helper 1 cells and T-helper 2 cells are found in peri-

    odontitis gingiva and granulation and that T-helper 2cells outnumber T-helper 1 cells. In particular, inter-

    leukin-10, an anti-inammatory cytokine, is found in

    abundance in periodontal lesions. The role of T-

    helper 1 cells and T-helper 2 cells, as well as the

    importance of the presence of various proinamma-

    tory and anti-inammatory cytokines, is still unclear.

    The possibility that the population of inltrative cells

    and the types of cytokines change over the progres-

    sion of the disease has been considered and, if this

    concept can be further dened, could be very valu-

    able in identifying the prognosis of early lesions and

    susceptible individuals (21, 45, 56, 57, 60, 77).

    Differences in chronic andaggressive periodontitishistopathology

    In both chronic periodontitis and aggressive peri-

    odontitis the cytokine proles are similar in dis-

    eased tissues (57). Increased numbers of T-cells and

    decreased numbers of macrophages have been

    found in aggressive periodontitis compared with

    chronic inammatory periodontal disease (15). It is

    difcult to assess the importance of these similari-

    ties because it is possible that there are temporal

    changes in the prole as the disease progresses

    from an early stage to a more advanced stage. Typi-

    cally, only the chronic stages of disease have been

    assessed, so it is possible that earlier stages mayshow a variation in cellular or cytokine proles.

    These differences may also be associated with

    genetic variation between subjects who have aggres-

    sive periodontitis compared with those who develop

    chronic periodontitis. Other considerations, includ-

    ing the presence or absence of certain microorgan-

    isms and the severity and duration of the disease,

    may also affect cell populations.

    In the progression from gingivitis to periodontitis

    there is a distinct shift from a primarily T-cell lesion

    to a B-cell lesion (60). There has been some consider-

    ation regarding whether the progression of early

    periodontal lesions to more advanced stages involves

    a similar shift from cell-mediated immunity to

    humoral immunity. Thus far the evidence has been

    circumstantial, but the concept of this shift suggests

    that T-cells may determine an individuals suscepti-

    bility to advanced and possibly aggressive forms of

    periodontal diseases.

    The humoral immune response to

    periodontal pathogensAntibodies to all known periodontal pathogens are

    present in both gingival crevicular uid and serum.

    The titers of these antibodies have been measured

    in patients with disease and in those who have

    recovered from disease. The pattern of antibody

    titers appears to vary between individuals. However,

    titers typically increase immediately after therapy

    and then decrease thereafter, an indication of a

    favorable response. Several theories have been pro-

    posed regarding the interpretation of the antibody

    response. A high titer could presumably indicate apositive immune response and thus an appropriate

    ability to attack and remove the pathogen. On the

    other hand, a high titer could be caused by the

    bodys inability to remove the pathogenic source

    and thus to overproduce the antibody. There is sig-

    nicant interindividual variation in the antibody

    response; whether this response is related to indi-

    vidual genetic inuences is yet to be seen. If a cor-

    relation is determined to exist, this may be a crucial

    Kulkarni & Kinane

    86

  • 8/12/2019 sm5 (1)

    9/13

    way in which genetics and periodontal diseases are

    linked (70).

    Deciencies in host defenses

    Particularly in the diagnosis of cases of early-onset

    forms of periodontitis, systemic conditions must be

    eliminated. Multiple systemic conditions may beassociated with periodontal attachment loss and

    bone destruction and these need to be excluded

    before a diagnosis of aggressive periodontitis is made.

    Aggressive periodontitis ideally should present in

    patients with a clear medical history but this is not

    always the case and there is always the possibility that

    a patient with, for example, leukemia, may also have

    aggressive periodontitis, but this clearly complicates

    the diagnosis and thankfully is rare. In some cases,

    despite the absence of a signicant medical history,

    there may still exist an underlying medical problem

    (e.g. a polymorphonuclear neutrophil dysfunction)

    and aggressive periodontitis-like features may be the

    only manifestation of this disturbance. Leukocyte

    adhesion deciency and PapillonLefevre syndrome

    are two examples where the oral picture is inuenced

    by defective leucocyte function and the diagnosis

    may be confused with generalized aggressive peri-

    odontitis.

    During infection, polymorphonuclear neutrophils

    move from blood vessels toward a chemotactic

    source. In order to traverse the blood vessel, adhesion

    molecules are expressed on endothelial cells andpolymorphonuclear neutrophils. This results in a

    preponderance of polymorphonuclear neutrophils

    within the periodontal tissues during disease, and

    close examination of the histopathological features of

    periodontal disease indicates that the polymorpho-

    nuclear neutrophil is a critical feature of the host

    defense; furthermore, in neutropenias or in leukocyte

    adhesion deciency where the quantity or function of

    the polymorphonuclear neutrophils are impaired,

    periodontal destruction is excessive. Thus, polymor-

    phonuclear neutrophils have been considered impor-

    tant in aggressive periodontitis and it is necessary toevaluate deciencies and abnormalities in polymor-

    phonuclear neutrophil function as they will have a

    direct connection to effects on the periodontium.

    However, this does not mean that we know for de-

    nite that aggressive periodontitis is caused by dys-

    functional polymorphonuclear neutrophils or even

    by other leukocytes.

    A high percentage of those with localized aggressive

    periodontitis have been reported to show abnormal

    chemotaxis. This has not been shown to occur in all

    individuals with localized aggressive periodontitis but

    there does appear to be a familial aggregation pattern

    associated with this defect, suggesting that this may

    be an inherited abnormality (24, 33, 34).

    As mentioned previously, multiple systemic condi-

    tions are associated with early-onset forms of peri-

    odontal disease. PapillionLefevre syndrome is

    characterized by hyperkeratosis of the palms and ofthe soles of the feet and with severe, aggressive

    destruction of the periodontal tissues, resulting in

    early tooth loss in both the primary and permanent

    dentitions. PapillionLefevre syndrome is a result of

    mutations in the cathepsin C gene. This mutation is

    inherited in an autosomal-recessive manner. It has

    been suggested that polymorphisms in the cathepsin

    C gene may be associated with a nonsyndromic type

    of aggressive periodontitis. However, despite several

    studies this possibility has yet to be seen with consis-

    tency.

    Genetic predisposition

    Aggressive periodontitis is a multifactorial disease

    process in which several etiological factors are neces-

    sary for clinical presentation. Bacterial and host

    defenses clearly play a major role in disease. How-

    ever, there is signicant support to show that a

    genetic component exists in the pattern of disease

    presentation within families. This has a major impli-

    cation in the method in which aggressive periodonti-

    tis is screened for by the practitioner. Oncediagnosed, the siblings of the child or adolescent

    should also be screened.

    Although bacterial invasion of the periodontal

    pocket and a host immune response to the spe-

    cies is necessary in the pathogenesis of periodon-

    tal disease, it does not fully explain the variation

    in the degree to which the disease process is

    expressed in some individuals compared with oth-

    ers with similar risk factors. Additionally, the

    familial aggregation of cases of aggressive peri-

    odontitis indicates that there may be a signicant

    genetic component involved in the susceptibilityto this disease. Genetic studies in families with

    aggressive periodontitis show an inheritance pat-

    tern consistent with a gene of major effect. In

    some cases the likelihood of a sibling having the

    condition was as high as 50%. However, many of

    these studies have been limited to African-Ameri-

    can populations, so other patterns of inheritance

    may exist in different populations. It is more likely

    that aggressive periodontitis is caused by a num-

    Aggressive periodontitis host factors

    87

  • 8/12/2019 sm5 (1)

    10/13

    ber of polymorphisms resulting in a similar clinical

    appearance.

    Pathology

    Aggressive periodontitis presents very similarly to

    chronic periodontitis but with some key exceptions.

    As mentioned previously, there may be a dispropor-tionate amount of microbial deposits compared with

    the level of tissue destruction. Additionally, in local-

    ized aggressive periodontitis the areas of disease

    will be limited to the incisors and the rst molars.

    This localization suggests that the disease itself may

    be limited in some way, either by local factors or by

    age.

    The most frequently affected teeth the molars and

    the incisorsare the rst teeth to erupt into a mixed

    dentition and this pattern may be important in the

    disease process. In a typical eruption pattern the

    incisors and the molars erupt in children of 6

    8 years

    of age. There is then a gap for approximately 12 years

    before the remaining teeth erupt into the mouth

    until a permanent dentition is reached by the age of

    1214 years. The fact that the disease limits itself to

    only the rst set of teeth may suggest that tolerance

    develops to the pathogenic cause over time.

    Other conditions affecting children and adoles-

    cents, such as juvenile arthritis and juvenile discitis,

    are time limited. These children outgrow the condi-

    tions as adults. The temporality of aggressive peri-

    odontitis in some patients may be caused by similarprocesses in which there is an immunological toler-

    ance over time to the source or a burnout of the

    lesion, resulting in a self-limiting pattern.

    Relevance of the host response indiagnosis and therapy

    Clinical diagnosis is the primary method by which

    aggressive periodontitis is recognized but may be

    supplemented with microbiological and family segre-

    gation analysis. Ideally we would have a genetic diag-nostic test but this has so far been elusive and it may

    be that a haplotype or group of polymorphisms may

    be what genetically predisposes to aggressive peri-

    odontitis. Because of the rare, yet potentially serious,

    consequences of early onset forms of periodontitis,

    early recognition and diagnosis is very important (3).

    A thorough periodontal examination is necessary

    for the diagnosis of aggressive periodontitis. Because

    of the rarity of the condition it is not practical to com-

    plete a thorough periodontal examination for every

    child or adolescent. However, patients should be rou-

    tinely screened for periodontal disease and a more

    comprehensive periodontal examination would be

    warranted if screening suggests that periodontal dis-

    ease could be present.

    In many cases of aggressive periodontitis there is a

    disproportionate amount of disease progression in

    comparison with the amount of localized microbialdeposits. Consequently, there may be little clinically

    visible sign of disease, particularly in the early stages.

    Bitewing radiographs are routinely taken in children

    and adolescents and may be used for initial screening

    purposes. Once aggressive periodontitis is suspected

    a comprehensive periodontal examination should be

    completed.

    Given the high incidence of aggressive periodontitis

    in families, all siblings, parents and offspring should

    also be screened for the condition, as there is 50%

    likelihood that the disease will be present. Although

    the disease may not be identical, it is important to fol-

    low patients who show even minor levels of involve-

    ment as this may represent the early stages of disease.

    Treatment of aggressive periodontitis can be chal-

    lenging. Successful treatment is associated with early

    diagnosis, elimination of the infectious organism and

    maintenance. Treatment with conventional debride-

    ment alone has not been shown to be effective in the

    long-term elimination of aggressive periodontitis.

    Antibiotic as an adjunct to debridement has been

    suggested for treatment. Treatment may be empiric,

    or microbiological testing may be used for selectionof appropriate antibiotics. Evidence in the literature

    suggests that the use of metronidazole plus amoxicil-

    lin, in combination with mechanical debridement, is

    very effective in chronic periodontitis and would also

    be useful in aggressive periodontitis in most cases.

    Other regimens have been tested, including the use of

    tetracycline, but this was based on the poorly

    supported contention that this disease was pre-

    dominantly caused by A. actinomycetemycomitans, a

    facultative anaerobe that would need an antibiotic

    capable of killing aerobes and anaerobes.

    Conclusions

    Aggressive periodontitis affects a small, but signi-

    cant, percentage of the population. Because of the

    rapidly progressing and aggressive nature of the dis-

    ease process these patients require early diagnosis

    and treatment in order to prevent further tissue dam-

    age and tooth loss. The role of the practitioner is not

    Kulkarni & Kinane

    88

  • 8/12/2019 sm5 (1)

    11/13

    only to treat those who already present with signi-

    cant disease but to prevent and educate those who

    are at high risk.

    Numerous factors play a role in aggressive peri-

    odontitis. Bacterial factors are well recognized as a

    key factor in the pathology of periodontitis; however,

    as described previously in this article, evidence to

    prove that a single pathogen,A. actinomycetemycomi-

    tans, is the universial primary etiology for disease isunsupported. Similarly, although host factors can also

    play an enormous role in the progression of disease,

    polymorphonuclear neutrophil dysfunction does not

    appear to be a cause for aggressive periodontitis in

    nonsyndromic individuals.

    The knowledge of genetic factors may be one of the

    most important aspects in the early detection of dis-

    ease. Because of the high level of familial aggregation

    it behooves the practitioner to screen all siblings and

    family members of an affected individual.

    References

    1. Abbas F, Van der Velden U, Hart AA, Moorer WR, Vroom

    TM, Scholte G. Bleeding/plaque ratio and the development

    of gingival inammation. J Clin Periodontol 1986: 13: 774

    782.

    2. Abe M, Tominaga K, Wakasa H. Phenotypic characterization

    of human B-lymphocyte subpopulations, particularly human

    CD5+ B-lymphocyte subpopulation within the mantle zones

    of secondary follicles.Leukemia1994:8: 10391044.

    3. Albandar JM. Aggressive periodontitis: case denition and

    diagnostic criteria.Periodontol 20002014:65: 1326.

    4. Albandar JM. Global risk factors and risk indicators for peri-odontal diseases.Periodontol 20002002:29: 177206.

    5. Albandar JM, Brown LJ, Loe H. Putative periodontal patho-

    gens in subgingival plaque of young adults with and without

    early-onset periodontitis.J Periodontol1997:68: 973981.

    6. Albandar JM, Brunelle JA, Kingman A. Destructive peri-

    odontal disease in adults 30 years of age and older in the

    United States, 19881994.J Periodontol1999:70: 1329.

    7. Albandar JM, DeNardin AM, Adesanya MR, Diehl SR, Winn

    DM. Associations between serum antibody levels to peri-

    odontal pathogens and early-onset periodontitis. J Period-

    ontol2001:72: 14631469.

    8. Albandar JM, Tinoco EM. Global epidemiology of periodon-

    tal diseases in children and young persons. Periodontol

    20002002:29: 153

    176.

    9. Anderson HH, Rapley JW, Williams DR. Gingival over-

    growth with valproic acid: a case report. ASDC J Dent Child

    1997:64: 294297.

    10. Benakanakere M, Kinane DF. Innate cellular responses to

    the periodontal biolm.Front Oral Biol2012:15: 4155.

    11. Brown J, Wang H, Hajishengallis GN, Martin M. TLR-signal-

    ing networks: an integration of adaptor molecules, kinases,

    and cross-talk.J Dent Res2011:90: 417427.

    12. Carlos JP, Wolfe MD, Zambon JJ, Kingman A. Periodontal

    disease in adolescents: some clinical and microbiologic

    correlates of attachment loss. J Dent Res 1988: 67: 1510

    1514.

    13. Dahlen G, Manji F, Baelum V, Fejerskov O. Black-pig-

    mentedBacteroidesspecies and Actinobacillus actinomyce-

    temcomitans in subgingival plaque of adult Kenyans.J Clin

    Periodontol1989:16: 305310.

    14. Danks JA, McHale JC, Clark SP, Chou ST, Scurry JP, Ingleton

    PM, Martin TJ. In situ hybridization of parathyroid hormone-

    related protein in normal skin, skin tumors, and gynecologi-

    cal cancers using digoxigenin-labeled probes and antibody

    enhancement.J Histochem Cytochem1995: 43: 5

    10.

    15. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner ACR, Yu W-

    H, Lakshmanan A, Wade WG. The human oral microbiome.

    J Bacteriol2010:192: 50025017.

    16. Ebersole JL, Cappelli D, Sandoval MN. Subgingival distribu-

    tion of A. actinomycetemcomitans in periodontitis. J Clin

    Periodontol1994:21: 6575.

    17. Eisenmann AC, Eisenmann R, Sousa O, Slots J. Microbio-

    logical study of localized juvenile periodontitis in Panama.

    J Periodontol1983: 54: 712713.

    18. Engebretson SP, Grbic JT, Singer R, Lamster IB. GCF IL-

    1beta proles in periodontal disease. J Clin Periodontol

    2002:29: 4853.

    19. Eskan MA, Rose BG, Benakanakere MR, Zeng Q, Fujioka D,Martin MH, Lee M-J, Kinane DF. TLR4 and S1P receptors

    cooperate to enhance inammatory cytokine production in

    human gingival epithelial cells. Eur J Immunol 2008: 38:

    11381147.

    20. Faveri M, Mayer MPA, Feres M, de Figueiredo LC, Dewhirst

    FE, Paster BJ. Microbiological diversity of generalized

    aggressive periodontitis by 16S rRNA clonal analysis. Oral

    Microbiol Immunol2008:23: 112118.

    21. Fujihashi K, Beagley KW, Kono Y, Aicher WK, Yamamoto M,

    DiFabio S, Xu-Amano J, McGhee JR, Kiyono H. Gingival

    mononuclear cells from chronic inammatory periodontal

    tissues produce interleukin (IL)-5 and IL-6 but not IL-2 and

    IL-4.Am J Pathol1993:142: 12391250.

    22. Garrison SW, Nichols FC. LPS-elicited secretory responsesin monocytes: altered release of PGE2 but not IL-1 beta in

    patients with adult periodontitis.J Periodontal Res1989:24:

    8895.

    23. Gemmell E, Seymour GJ. Gamma delta T lymphocytes in

    human periodontal disease tissue. J Periodontol1995: 66:

    780785.

    24. Genco RJ, Zambon JJ, Murray PA. Serum and gingivaluid

    antibodies as adjuncts in the diagnosis of Actinobacillus

    actinomycetemcomitans-associated periodontal disease.

    J Periodontol1985:56: 4150.

    25. Gmur R, Guggenheim B. Interdental supragingival plaque

    a natural habitat ofActinobacillus actinomycetemcomitans,

    Bacteroides forsythus, Campylobacter rectus, and Prevotella

    nigrescens.J Dent Res1994:73: 1421

    1428.26. Grossi SG, Zambon JJ, Ho AW, Koch G, Dunford RG, Mach-

    tei EE, Norderyd OM, Genco RJ. Assessment of risk for peri-

    odontal disease. I. Risk indicators for attachment loss.

    J Periodontol1994:65: 260267.

    27. Hatton O, Phillips LK, Vaysberg M, Hurwich J, Krams SM,

    Martinez OM. Syk activation of phosphatidylinositol 3-

    kinase/Akt prevents HtrA2-dependent loss of X-linked

    inhibitor of apoptosis protein (XIAP) to promote survival of

    Epstein-Barr virus+ (EBV+) B cell lymphomas. J Biol Chem

    2011:286: 3736837378.

    Aggressive periodontitis host factors

    89

  • 8/12/2019 sm5 (1)

    12/13

    28. Heller D, Silva-Boghossian CM, do Souto RM, Colombo

    APV. Subgingival microbial proles of generalized aggres-

    sive and chronic periodontal diseases.Arch Oral Biol2012:

    57: 973980.

    29. Ito H, Harada Y, Matsuo T, Ebisu S, Okada H. Possible role

    of T cells in the establishment of IgG plasma cell-rich

    periodontal lesionaugmentation of IgG synthesis in the

    polyclonal B cell activation response by autoreactive T cells.

    J Periodontal Res1988:23: 3945.

    30. Jenkins WM, Kinane DF. The high riskgroup in periodon-

    titis.Br Dent J1989:167: 168

    171.

    31. Kawai T, Akira S. TLR signaling. Semin Immunol 2007: 19:

    2432.

    32. Kinane DF, Attstrom R. Advances in the pathogenesis of

    periodontitis. Group B consensus report of the fth Euro-

    pean Workshop in Periodontology. J Clin Periodontol2005:

    32(Suppl 6): 130131.

    33. Kinane DF, Cullen CF, Johnston FA, Evans CW. Neutrophil

    chemotactic behaviour in patients with early-onset forms

    of periodontitis (I). Leading front analysis in Boyden cham-

    bers.J Clin Periodontol1989:16: 242246.

    34. Kinane DF, Cullen CF, Johnston FA, Evans CW. Neutrophil

    chemotactic behaviour in patients with early-onset forms

    of periodontitis (II). Assessment using the under agarosetechnique.J Clin Periodontol1989:16: 247251.

    35. Kinane DF, Hajishengallis G. Polymicrobial infections,

    biolms, and beyond.J Clin Periodontol2009:36: 404405.

    36. Kinane DF, Hart TC. Genes and gene polymorphisms asso-

    ciated with periodontal disease. Crit Rev Oral Biol Med

    2003:14: 430449.

    37. Kinane DF, Marshall GJ. Periodontal manifestations of sys-

    temic disease.Aust Dent J2001:46: 212.

    38. Lang NPBP, Cullinam M, Jeffcoat M, Mombelli A, Murakami

    S, Page R, Papapanou P, Tonetti M, Van Dyke T. Interna-

    tional classication workshop. Consensus report: aggressive

    periodontitis.Ann Periodontol1999:4: 53.

    39. Lappin DF, Koulouri O, Radvar M, Hodge P, Kinane DF.

    Relative proportions of mononuclear cell types in periodon-tal lesions analyzed by immunohistochemistry. J Clin Peri-

    odontol1999:26: 183189.

    40. Lappin DF, MacLeod CP, Kerr A, Mitchell T, Kinane DF.

    Anti-inammatory cytokine IL-10 and T cell cytokine pro-

    le in periodontitis granulation tissue. Clin Exp Immunol

    2001:123: 294300.

    41. Lie MA, Danser MM, van der Weijden GA, Timmerman MF,

    de Graaff J, van der Velden U. Oral microbiota in subjects

    with a weak or strong response in experimental gingivitis.

    J Clin Periodontol1995:22: 642647.

    42. Lie MA, van der Weijden GA, Timmerman MF, Loos BG,

    van Steenbergen TJ, van der Velden U. Oral microbiota

    in smokers and non-smokers in natural and experimen-

    tally-induced gingivitis. J Clin Periodontol 1998: 25:677686.

    43. Listgarten MA, Wong MY, Lai CH. Detection ofActinobac-

    illus actinomycetemcomitans, Porphyromonas gingivalis,

    and Bacteroides forsythus in an A. actinomycetemcomi-

    tans-positive patient population. J Periodontol 1995: 66:

    158164.

    44. Loe H, Theilade E, Jensen SB. Experimental Gingivitis In

    Man.J Periodontol1965:36: 177187.

    45. Lundqvist C, Baranov V, Teglund S, Hammarstrom S, Ham-

    marstrom ML. Cytokine prole and ultrastructure of intra-

    epithelial gamma delta T cells in chronically inamed

    human gingiva suggest a cytotoxic effector function.

    J Immunol1994:153: 23022312.

    46. Mackler BF, Waldrop TC, Schur P, Robertson PB, Levy BM.

    IgG subclasses in human periodontal disease. I. Distribu-

    tion and incidence of IgG subclass bearing lymphocytes

    and plasma cells.J Periodontal Res1978:13: 109119.

    47. Mandell RL, Ebersole JL, Socransky SS. Clinical immuno-

    logic and microbiologic features of active disease sites

    in juvenile periodontitis. J Clin Periodontol 1987: 14:

    534

    540.

    48. Manhart SS, Reinhardt RA, Payne JB, Seymour GJ, Gemmell

    E, Dyer JK, Petro TM. Gingival cell IL-2 and IL-4 in early-

    onset periodontitis.J Periodontol1994:65: 807813.

    49. McNabb H, Mombelli A, Gmur R, Mathey-Dinc S, Lang NP.

    Periodontal pathogens in the shallow pockets of immi-

    grants from developing countries. Oral Microbiol Immunol

    1992:7: 267272.

    50. Medzhitov R. Innate immunity: quo vadis? Nat Immunol

    2010:11: 551553.

    51. Meng HX, Zheng LF. T cells and T-cell subsets in periodon-

    tal diseases.J Periodontal Res1989:24: 121126.

    52. Okada H, Ito H, Harada Y. T-cell requirement for establish-

    ment of the IgG-dominant B-cell lesion in periodontitis.J Periodontal Res1987:22: 187189.

    53. Okada H, Kida T, Yamagami H. Identication and distribution

    of immunocompetent cells in inamed gingiva of human

    chronic periodontitis.Infect Immun1983:41: 365374.

    54. Page RC, Schroeder HE. Pathogenesis of inammatory peri-

    odontal disease. A summary of current work. Lab Invest

    1976:34: 235249.

    55. Paster BJ, Dewhirst FE. Phylogenetic foundation of spiro-

    chetes.J Mol Microbiol Biotechnol2000:2: 341344.

    56. Roberts FA, McCaffery KA, Michalek SM. Prole of cytokine

    mRNA expression in chronic adult periodontitis. J Dent Res

    1997:76: 18331839.

    57. Salvi GE, Lawrence HP, Offenbacher S, Beck JD. Inuence

    of risk factors on the pathogenesis of periodontitis. Period-ontol 20001997:29: 173201.

    58. Sandholm L, Tolo K, Olsen I. Salivary IgG, a parameter of

    periodontal disease activity? High responders to Actinobac-

    illus actinomycetemcomitansY4 in juvenile and adult peri-

    odontitis.J Clin Periodontol1987:14: 289294.

    59. Seymour GJ, Greenspan JS. The phenotypic characteriza-

    tion of lymphocyte subpopulations in established human

    periodontal disease.J Periodontal Res1979:14: 3946.

    60. Seymour RA, Heasman PA. Tetracyclines in the manage-

    ment of periodontal diseases. A review. J Clin Periodontol

    1995:22: 2235.

    61. Shapira L, Soskolne WA, Sela MN, Offenbacher S, Barak V.

    The secretion of PGE2, IL-1 beta, IL-6, and TNF alpha by

    adherent mononuclear cells from early onset periodontitispatients.J Periodontol1994:65: 139146.

    62. Sigusch B, Klinger G, Glockmann E, Simon HU. Early-onset

    and adult periodontitis associated with abnormal cytokine

    production by activated T lymphocytes. J Periodontol1998:

    69: 10981104.

    63. Sjodin B, Matsson L, Unell L, Egelberg J. Marginal bone loss

    in the primary dentition of patients with juvenile periodon-

    titis.J Clin Periodontol1993:20: 3236.

    64. Slots J, Genco RJ. Black-pigmented Bacteroides species,

    Capnocytophaga species, and Actinobacillus actinomyce-

    Kulkarni & Kinane

    90

  • 8/12/2019 sm5 (1)

    13/13

    temcomitans in human periodontal disease: virulence

    factors in colonization, survival, and tissue destruction.

    J Dent Res1984:63: 412421.

    65. Slots J, Rams TE, Schonfeld SE. In vitro activity of chlorhexi-

    dine against enteric rods, pseudomonads and acinetobacter

    from human periodontitis. Oral Microbiol Immunol 1991:

    6: 6264.

    66. Socransky SS, Haffajee AD. The bacterial etiology of

    destructive periodontal disease: current concepts.J Period-

    ontol1992:63: 322331.

    67. Socransky SS, Tanner AC, Goodson JM, Haffajee AD, Walker

    CB, Ebersole JL, Sornberger GC. An approach to the deni-

    tion of periodontal disease syndromes by cluster analysis.

    J Clin Periodontol1982:9: 460471.

    68. Sugawara M, Yamashita K, Yoshie H, Hara K. Detection of,

    and anti-collagen antibody produced by, CD5-positive B

    cells in inamed gingival tissues.J Periodontal Res1992:27:

    489498.

    69. Susin C, Haas AN, Albandar JM. Epidemiology and demo-

    graphics of aggressive periodontitis. Periodontol 20002014:

    65: 2745.

    70. Takahashi K, Mooney J, Frandsen EV, Kinane DF. IgG

    and IgA subclass mRNA-bearing plasma cells in periodon-

    titis gingival tissue and immunoglobulin levels in thegingival crevicular uid. Clin Exp Immunol 1997: 107:

    158165.

    71. Tanner ACR, Paster BJ, Lu SC, Kanasi E, Kent R, Van Dyke

    T, Sonis ST. Subgingival and tongue microbiota during early

    periodontitis.J Dent Res2006:85: 318323.

    72. Tonetti MS, Mombelli A. Early-onset periodontitis. Ann

    Periodontol1999:4: 3953.

    73. Trombelli L, Tatakis DN, Scapoli C, Bottega S, Orlandini E,

    Tosi M. Modulation of clinical expression of plaque-

    induced gingivitis. II. Identication of high-responder

    and low-responder subjects. J Clin Periodontol2004: 31:

    239252.

    74. Wiedemann W, Lahrsow J, Naujoks R. The effect of peri-

    odontal resistance on experimental gingivitis. Dtsch Zah-

    narztl Z1979:34: 69.

    75. al-Yahfou Z, Mombelli A, Wicki A, Lang NP. The effect of

    plaque control in subjects with shallow pockets and high

    prevalence of periodontal pathogens. J Clin Periodontol

    1995:22: 7884.

    76. Yamazaki K, Nakajima T, Aoyagi T, Hara K. Immunohisto-

    logical analysis of memory T lymphocytes and activated B

    lymphocytes in tissues with periodontal disease. J Periodon-

    tal Res1993:28: 324334.

    77. Yamazaki K, Nakajima T, Hara K. Immunohistological anal-

    ysis of T cell functional subsets in chronic inammatory

    periodontal disease.Clin Exp Immunol1995:99: 384391.

    78. Yamazaki K, Nakajima T, Kubota Y, Gemmell E, Seymour

    GJ, Hara K. Cytokine messenger RNA expression in chronic

    in

    ammatory periodontal disease.Oral Microbiol Immunol1997:12: 281287.

    79. Zambon JJ, Umemoto T, De Nardin E, Nakazawa F, Chris-

    tersson LA, Genco RJ. Actinobacillus actinomycetemcomi-

    tansin the pathogenesis of human periodontal disease. Adv

    Dent Res1988:2: 269274.

    Aggressive periodontitis host factors

    91